SIMPLEX TRADING, LLC - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 167 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$62,000
-50.0%
86,989
+58.1%
0.00%
Q4 2021$124,000
-23.5%
55,035
+14.4%
0.00%
Q1 2021$162,000
-42.6%
48,118
-52.3%
0.00%
Q4 2020$282,000
+15.6%
100,822
+3.5%
0.00%
Q3 2020$244,000
-59.7%
97,449
+118.3%
0.00%
-100.0%
Q2 2020$606,000
-31.4%
44,648
-61.7%
0.00%
-50.0%
Q1 2020$883,000
+12.2%
116,586
-6.5%
0.00%0.0%
Q4 2019$787,000
+1024.3%
124,680
+593.0%
0.00%
Q3 2019$70,000
-71.0%
17,991
-63.9%
0.00%
-100.0%
Q2 2019$241,000
-19.1%
49,847
+36.6%
0.00%0.0%
Q1 2019$298,000
-0.3%
36,490
+7.8%
0.00%0.0%
Q3 2018$299,000
-38.2%
33,863
-30.2%
0.00%
-50.0%
Q2 2018$484,000
+2925.0%
48,518
+2633.4%
0.00%
+100.0%
Q1 2018$16,000
-48.4%
1,775
-16.3%
0.00%0.0%
Q4 2017$31,000
-35.4%
2,121
-13.1%
0.00%
-50.0%
Q3 2017$48,000
+500.0%
2,441
+306.8%
0.00%
Q2 2017$8,000
-77.8%
600
-84.8%
0.00%
-100.0%
Q1 2017$36,000
-87.2%
3,954
-85.4%
0.00%
-88.2%
Q4 2016$282,000
+38.2%
27,132
+20.2%
0.02%
+21.4%
Q3 2016$204,000
+60.6%
22,572
+32.7%
0.01%
+75.0%
Q2 2016$127,000
+41.1%
17,005
+68.4%
0.01%
+14.3%
Q1 2016$90,000
+233.3%
10,097
+370.3%
0.01%
+250.0%
Q4 2015$27,000
-91.6%
2,147
-93.5%
0.00%
-91.3%
Q3 2015$320,00033,1480.02%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders